Nicotine Mini Lozenge
Product Images NDC 72888-187

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Nicotine Mini (NDC 72888-187). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advagen Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-55)

This appears to be the packaging and drug facts information for a nicotine replacement therapy product, specifically a 2mg lozenge. It includes warnings not to sell to minors and not to sell in vending machines or from sources where proof of age cannot be verified. The product is intended as a stop smoking aid and includes dosage instructions based on the user's smoking habits upon waking up. The rest of the text is difficult to decipher due to errors and is not clear.*

FDA Label Image

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-56)

This appears to be a drug facts label for a nicotine polacrilex lozenge, 2mg strength, used as a stop smoking aid. The label includes information on how to use the product, warnings about age restrictions for purchase, and dosage information. There are also instructions for individuals who smoke their first cigarette within 30 minutes of waking up.*

FDA Label Image

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-53)

This is a description of a nicotine lozenge that comes in a pack of 27. It is a 2mg dose for a stop-smoking aid and is recommended for those who smoke their first cigarette after 30 minutes of waking up. If someone smokes within the first 30 minutes of waking up, they should use the 4mg Nicotine Polacrilex Lozenge. The flavor is mint, and it is not for sale to those under age 18. Proof of age is required, and it cannot be sold in vending machines or from any source where proof of age cannot be verified. The rest of the text is not available.*

FDA Label Image

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-53)

This is a description of a stop smoking aid product called Nicotine Polacrilex in the form of a mint flavored lozenge. Each lozenge contains 2mg of nicotine. There are 27 lozenges in a package. The packaging contains instructions, warnings, and contact information for poison control. The product has a tamper-evident feature to ensure safety. The manufacturer is Ubicon Research located in India and the product is distributed by Dagen Pharma in Parsbor, UK. Contact information for questions is provided and the product has a recommended storage temperature.*

FDA Label Image

Nicotine Polacrilex Lozenge, 2 mg (NDC 72888-186-54)

This is a product designed to help people quit smoking. It is a Nicotine Polacrilex lozenge, to be used as a stop smoking aid by those who smoke their first cigarette more than 30 minutes after waking up. For those who smoke their first within this time frame, a 4mg lozenge is recommended. It is not for sale to individuals under 18 and sale from vending machines or sources where proof of age cannot be verified is prohibited. The product comes with 3 bottles of 27 lozenges each (total of 81 lozenges). There is a Lot # and an expiration date visible on the package.*

FDA Label Image

Nicotine Polacrilex Lozenge, 4 mg (NDC 72888-187-53)

This text appears to be a drug facts label belonging to a product called "Nicotine Polacrilex Lozenge, 4 mg" intended as a stop smoking aid for those who smoke their first cigarette within 30 minutes of waking up. It is not for sale to individuals under 13 years of age, and proof of age may be required for purchase. The label contains information on recommended usage, dosage, and potential side effects.*

FDA Label Image

Nicotine Polacrilex Lozenge, 4 mg (NDC 72888-187-53)

This is a drug facts label for Acavei Nicotine Polacrilex Lozenge of 4mg. It is a stop smoking aid for those who smoke their first cigarette within 30 minutes of waking up. It comes in a pack of 135 lozenges, with 5 bottles of 27 lozenges each. Proof of age is required before purchase, and it is not recommended for sale to those under 18 years of age. There is an expiration date listed on the label.*

FDA Label Image

Nicotine Polacrilex Lozenge, 4 mg (NDC 72888-187-53)

This is a Drug Facts label of nicotine polacrilex lozenges containing 4 mg of the active ingredient, meant to aid in stopping smoking. It should not be sold to those under 18 years of age, and proof of age is required. It should not be sold via vending machines or any source where age cannot be verified. The optimal usage is for those who smoke their first cigarette within 30 minutes after waking up, and for others, the 2mg nicotine polacrilex lozenge is recommended. The product comes in a package that contains 27 lozenges with 4mg each and weighs 0.15g.*

FDA Label Image

Nicotine Polacrilex Lozenge, 4 mg (NDC 72888-187-53)

This is a product description for a stop smoking aid that comes in the form of lozenges. The specific product contains nicotine polacrilex and comes in a mint flavor with 27 lozenges per bottle, each containing 4mg of nicotine. The text also includes dosage instructions, safety warnings, storage instructions, and contact information for any questions. The product is manufactured in India and distributed in the USA by Advagen Pharma Limited.*

FDA Label Image

Nicotine Polacrilex Lozenge, 4 mg (NDC 72888-187-53)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.